Clinical Trial Update: An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Open-label follow-on Phase 2 trial assessing long-term safety and efficacy of oral SPM 927 in painful diabetic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• SPM 927 (SPM 927)

Snippet

Sponsor: UCB Pharma | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED